Listed

TherapeuticsMD, Inc.: Form 10-Q for the period ended Jun 30, 2011

Filed with the SEC on Aug 15, 2011 and accepted by EDGAR at Aug 15, 2011, 15:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Interest expense3 months2011-04-01 to 2011-06-30$3.5kus-gaap:InterestExpense
Interest expense6 months2011-01-01 to 2011-06-30$7.4kus-gaap:InterestExpense
Net income3 months2011-04-01 to 2011-06-30−$57.1kus-gaap:NetIncomeLoss
Net income6 months2011-01-01 to 2011-06-30$556.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2011-04-01 to 2011-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2011-01-01 to 2011-06-30$0.03us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2011-01-01 to 2011-06-30−$147.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Current assetsAt period end2011-06-30$5.5kus-gaap:AssetsCurrent
Total assetsAt period end2011-06-30$5.5kus-gaap:Assets
Current liabilitiesAt period end2011-06-30$356.6kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-06-30$356.6kus-gaap:Liabilities
Shareholders' equityAt period end2011-06-30−$351.2kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001387131-11-001704. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.